{"log_id": 3278133036457985889, "direction": 0, "words_result_num": 41, "words_result": [{"probability": {"variance": 0.000692, "average": 0.991917, "min": 0.831643}, "location": {"width": 779, "top": 227, "height": 65, "left": 210}, "words": "4.血浆中HDL和HDL2胆固醇浓度升高,LDL胆固醇浓度降低,甘油三脂水平升高"}, {"probability": {"variance": 0.000344, "average": 0.991346, "min": 0.9409}, "location": {"width": 184, "top": 308, "height": 38, "left": 213}, "words": "5.葡萄糖耐量降低"}, {"probability": {"variance": 0.005054, "average": 0.972435, "min": 0.741083}, "location": {"width": 268, "top": 361, "height": 41, "left": 215}, "words": "6.对甲吡酮试验的反应下降"}, {"probability": {"variance": 3.8e-05, "average": 0.996944, "min": 0.976912}, "location": {"width": 271, "top": 420, "height": 39, "left": 180}, "words": "[孕妇及哺乳期妇女用药]"}, {"probability": {"variance": 0.006695, "average": 0.972787, "min": 0.630913}, "location": {"width": 401, "top": 442, "height": 45, "left": 227}, "words": "倍美力不应用于怀孕妇女,(见[禁忌])"}, {"probability": {"variance": 0.000832, "average": 0.991584, "min": 0.839338}, "location": {"width": 814, "top": 478, "height": 64, "left": 229}, "words": "服用雌激素可使哺乳的质量和数量降低。服药母亲的乳汁中可以检测到雌激素。哺乳"}, {"probability": {"variance": 5e-06, "average": 0.998508, "min": 0.991817}, "location": {"width": 224, "top": 536, "height": 36, "left": 183}, "words": "期妇女不应使用雌激素"}, {"probability": {"variance": 0.000154, "average": 0.98593, "min": 0.968466}, "location": {"width": 93, "top": 564, "height": 32, "left": 914}, "words": "制约有"}, {"probability": {"variance": 0.001832, "average": 0.984588, "min": 0.799155}, "location": {"width": 830, "top": 590, "height": 67, "left": 232}, "words": "尽管雌激素已经被用于治疗某些青春期发育迟缓的青少年来诱导青春期发育,关于儿"}, {"probability": {"variance": 8.5e-05, "average": 0.989979, "min": 0.974383}, "location": {"width": 123, "top": 597, "height": 29, "left": 185}, "words": "[儿童用药]"}, {"probability": {"variance": 0.002034, "average": 0.984418, "min": 0.811527}, "location": {"width": 353, "top": 644, "height": 43, "left": 185}, "words": "童用药的安全性和有效性还没有建立"}, {"probability": {"variance": 0.03913, "average": 0.799093, "min": 0.601279}, "location": {"width": 101, "top": 650, "height": 48, "left": 888}, "words": "药商"}, {"probability": {"variance": 0.000589, "average": 0.992664, "min": 0.851215}, "location": {"width": 818, "top": 673, "height": 70, "left": 234}, "words": "长时间的大量、重复给予的雌激素会加速骨骺闭合,对于正常发育中的儿童如果在"}, {"probability": {"variance": 1.7e-05, "average": 0.997727, "min": 0.981456}, "location": {"width": 834, "top": 706, "height": 66, "left": 188}, "words": "生理的青春期完成之前用药,可能导致身材矮小。如果患者在骨骼发育完成前服用雌激"}, {"probability": {"variance": 3e-05, "average": 0.997078, "min": 0.973907}, "location": {"width": 658, "top": 744, "height": 55, "left": 188}, "words": "素,在服药期间建议定期进行监控其对骨骼成熟度和骨骺中心的影响"}, {"probability": {"variance": 3e-06, "average": 0.999193, "min": 0.990601}, "location": {"width": 815, "top": 790, "height": 62, "left": 236}, "words": "青春期女孩接受雌激素治疗,也能导致乳房过早发育和阴道角质化,并可能导致阴道"}, {"probability": {"variance": 2.1e-05, "average": 0.997924, "min": 0.974191}, "location": {"width": 835, "top": 820, "height": 64, "left": 189}, "words": "流血。男孩接受雌激素治疗,可以改变通常的青春期过程,导致男孩乳房女性化。(见"}, {"probability": {"variance": 0.022918, "average": 0.935711, "min": 0.440927}, "location": {"width": 219, "top": 875, "height": 38, "left": 194}, "words": "适应症]和[用法用量])"}, {"probability": {"variance": 0.00396, "average": 0.982201, "min": 0.60407}, "location": {"width": 793, "top": 934, "height": 62, "left": 242}, "words": "WHI一单独使用雌激素亚组研究的全部受试者中,46%的受试者(n=4,943)年龄是"}, {"probability": {"variance": 0.000456, "average": 0.985396, "min": 0.93886}, "location": {"width": 121, "top": 935, "height": 33, "left": 192}, "words": "[老年用药]"}, {"probability": {"variance": 0.0017, "average": 0.991683, "min": 0.721818}, "location": {"width": 851, "top": 963, "height": 64, "left": 193}, "words": "65岁及以上,其中7.1%(n=767)是75岁及以上。倍美力相对于安慰剂,小于75岁的"}, {"probability": {"variance": 0.000331, "average": 0.994189, "min": 0.91361}, "location": {"width": 447, "top": 1009, "height": 47, "left": 196}, "words": "老人用药后中风的相对风险高于75岁或以上者"}, {"probability": {"variance": 0.002361, "average": 0.982547, "min": 0.714948}, "location": {"width": 807, "top": 1047, "height": 61, "left": 243}, "words": "WHI雌/孕激素合用亚组研究中,44%的受试者(n=7,320)年龄在65-74岁之间,而且"}, {"probability": {"variance": 0.008298, "average": 0.967283, "min": 0.577264}, "location": {"width": 843, "top": 1074, "height": 68, "left": 196}, "words": "其中6.6%(n=1095)是75岁及以上。在75岁或以上的老人观察到用药后非致死性中风和"}, {"probability": {"variance": 0.000894, "average": 0.989262, "min": 0.825928}, "location": {"width": 859, "top": 1107, "height": 63, "left": 195}, "words": "侵润性乳腺癌的相对风险高于较年轻的受试者。75岁以上妇女中观察到雌激素加孕激素组"}, {"probability": {"variance": 0.0001, "average": 0.995699, "min": 0.946716}, "location": {"width": 849, "top": 1136, "height": 62, "left": 198}, "words": "与安慰剂组相比,非致死性中风和侵润性乳腺癌的风险增加,分别为75例对24例每1000"}, {"probability": {"variance": 4.3e-05, "average": 0.995416, "min": 0.975805}, "location": {"width": 427, "top": 1180, "height": 46, "left": 199}, "words": "名妇女每年和52例对12例每10000名妇女每年"}, {"probability": {"variance": 0.009312, "average": 0.965524, "min": 0.556879}, "location": {"width": 762, "top": 1218, "height": 60, "left": 247}, "words": "WHI- WHIMS单独使用雌激素亚组研究中,2947名切除子宫妇女(年龄65-79"}, {"probability": {"variance": 0.000582, "average": 0.988565, "min": 0.894716}, "location": {"width": 816, "top": 1246, "height": 65, "left": 200}, "words": "岁),随机分组,每天服用0.625mg倍美力或者安慰剂;81%(n=2383)为65-74岁"}, {"probability": {"variance": 0.000704, "average": 0.990265, "min": 0.840803}, "location": {"width": 850, "top": 1303, "height": 64, "left": 203}, "words": "现,单用雌激素组可能性痴呆的绝对风险为37例每10,000名妇女每年,而安慰剂组为25"}, {"probability": {"variance": 0.00182, "average": 0.944373, "min": 0.901717}, "location": {"width": 25, "top": 1312, "height": 22, "left": 213}, "words": "9%"}, {"probability": {"variance": 0.00028, "average": 0.994071, "min": 0.904553}, "location": {"width": 756, "top": 1275, "height": 58, "left": 297}, "words": "64)为75岁或以上。约50%妇女以往没有使用过ERT。平均5.2年的随访后发"}, {"probability": {"variance": 0.022103, "average": 0.91815, "min": 0.425003}, "location": {"width": 832, "top": 1334, "height": 62, "left": 200}, "words": "例每10.000名妇女每年(RR1.49.95%C10.832.66)。(见[注意事项]一告,痴呆"}, {"probability": {"variance": 0.013704, "average": 0.956586, "min": 0.509758}, "location": {"width": 806, "top": 1386, "height": 66, "left": 250}, "words": "在 WHMS雌/孕激素合用亚组研究中,4532名(年龄63岁绝经后妇女,随机分"}, {"probability": {"variance": 0.03258, "average": 0.895782, "min": 0.395901}, "location": {"width": 852, "top": 1414, "height": 65, "left": 204}, "words": "组,服用雌激索加孕激素0.625mg/2.5mg)或者安慰,平均随访4车:其中,65-74岁"}, {"probability": {"variance": 0.028759, "average": 0.910284, "min": 0.541173}, "location": {"width": 216, "top": 1446, "height": 32, "left": 846}, "words": "大多数妇女(80%)以"}, {"probability": {"variance": 0.048268, "average": 0.853181, "min": 0.416059}, "location": {"width": 130, "top": 1478, "height": 25, "left": 208}, "words": "受试者占"}, {"probability": {"variance": 0.020512, "average": 0.922275, "min": 0.395283}, "location": {"width": 653, "top": 1473, "height": 52, "left": 412}, "words": "在平均随访4年后,雌激素加孕激素组发展能性采的绝对风险"}, {"probability": {"variance": 1.7e-05, "average": 0.99432, "min": 0.989791}, "location": {"width": 28, "top": 1475, "height": 17, "left": 408}, "words": "729"}, {"probability": {"variance": 0.034139, "average": 0.916489, "min": 0.358703}, "location": {"width": 321, "top": 1455, "height": 38, "left": 482}, "words": "75岁及以上受试者占18(=803"}, {"probability": {"variance": 0.031729, "average": 0.905379, "min": 0.475798}, "location": {"width": 153, "top": 1502, "height": 33, "left": 208}, "words": "往没有使用过H"}], "language": 3}